FIELD: medicine.
SUBSTANCE: invention relates to medicine and is intended for diagnostics of minor forms of endometriosis. Concentration of a pro-inflammatory cytokine, interleukin 6 (IL-6) and a carbohydrate antigen, a CA125 tumour marker, are determined in the venous blood of women. Additionally, the levels of IL-6 and alpha-2-microglobulin of fertility, glycodelin, are determined in the menstrual blood. At an IL-6 concentration of 5.3±2.4 pg/ml and a CA125 concentration of 14.6±3.8 U/L in venous blood, an IL-6 concentration of 8.7±3.1 pg/ml and a glycodelin level of 49.1±5.6 ng/ml in menstrual blood, minor forms of endometriosis are diagnosed.
EFFECT: invention ensures increased accuracy of diagnostics.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF COMPLICATED PREGNANCY IN WOMEN WITH GENITAL ENDOMETRIOSIS | 2017 |
|
RU2640022C1 |
| METHOD FOR DIAGNOSIS OF EARLY STAGES OF EXTERNAL GENITAL ENDOMETRIOSIS | 2015 |
|
RU2592240C1 |
| METHOD FOR EARLY DIAGNOSIS OF NEOPLASTIC TRANSFORMATION OF ENDOMETRIOID OVARIAN CYSTS | 2020 |
|
RU2730952C1 |
| METHOD FOR DIAGNOSTICS OF INITIAL FORMS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2022 |
|
RU2793841C1 |
| METHOD OF DIAGNOSTICS OF NON-TUMOUROUS LESIONS OF OVARIES AT LATE TERMS OF PREGNANCY | 2009 |
|
RU2410695C1 |
| METHOD FOR DIAGNOSIS OF EXTERNAL GENITAL ENDOMETRIOSIS | 2021 |
|
RU2756027C1 |
| METHOD FOR DIAGNOSING EXTERNAL GENITAL ENDOMETRIOSIS | 2021 |
|
RU2761539C1 |
| METHOD OF DIAGNOSTICS OF ENDOMETRIOSIS IN WOMEN WITH INFERTILITY | 2017 |
|
RU2657802C1 |
| METHOD OF NON-INVASIVE EARLY DIAGNOSIS OF ENDOMETRIOSIS | 2019 |
|
RU2726971C1 |
| METHOD FOR PREDICTION OF MISSED MISCARRIAGE | 2011 |
|
RU2465589C1 |
